Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2007
11/21/2007EP1855529A2 Spiroketal-substituted cyclic ketoenols
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1320571B1 3-spiro-cyanin fluorochromes and their use in bioassays
11/21/2007CN101076516A Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/21/2007CN101076330A Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074232A Production of 7-ethyl-camptothecin
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349888C Medicine compound
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2007US7297788 Regioselective hydroxylation, functionalisation and protection of spirolactams
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007WO2007129083A1 Anti-viral pyrimidine nucleoside derivatives
11/15/2007WO2007128782A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/15/2007WO2007110340A3 Pyrimidine, quinazoline, pteridine and triazine derivatives
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265328 2-(6-oxo-1,7-diaza-spiro[4.4]non-7-yl)-propionamides such as 4-(S)-hydroxy-5-(S)-[2-(S)-(1-isobutyl-6-oxo-1,7-diaza-spiro(S)-[4.4]non-7-yl)-propionylamino]-2-(R)-methyl-6-phenyl-hexanoic acid butylamide; inhibitors of aspartic proteases such as beta-secretase
11/15/2007US20070265249 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070264266 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents
11/15/2007CA2656780A1 Anti-viral pyrimidine nucleoside derivatives
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/15/2007CA2648831A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/14/2007EP1854798A2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
11/14/2007EP1854792A1 1-(2h)-isoquinolone derivative
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1383507B1 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
11/14/2007EP1362053B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1361895B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007CN101072780A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101070324A 10-desacetyl bacchatine III Taxane derivative and preparing method
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/13/2007US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007CA2410673C Indolinospiropyran compounds and methods for their manufacture
11/13/2007CA2258243C 4,7-dichlororhodamine dyes
11/13/2007CA2231052C Benzoxazepine compounds, their production and use as lipid lowering agents
11/08/2007WO2007127183A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007WO2007126046A1 Process for production of camptothecin derivative
11/08/2007WO2007125061A1 Spirocompounds useful as modulators for dopamine d3 receptors
11/08/2007WO2007124903A1 Spirocyclic cyclohexane derivative with analgesic properties
11/08/2007WO2007087220A3 The total synthesis of ecteinascidin 743 and derivatives thereof
11/08/2007WO2007038868A3 Novel enediyne compound and uses thereof
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259905 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
11/08/2007US20070259868 phosphodiesterase PDE4 inhibitor; preparing claimed 3-(dialkoxy)phenyl-4-aminopyran intermediate from the claimed 4-oxo compound starting with hydrobromination of the corresponding phenylacetylene; antiinflammatory for airways and skin; respiratory; bronchodilator
11/08/2007US20070259850 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
11/08/2007US20070259286 Reversible Piezochromic Systems
11/08/2007CA2650295A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007CA2650290A1 Pharmaceutical compounds
11/08/2007CA2649676A1 Process for production of camptothecin derivative
11/08/2007CA2649349A1 Spirocyclic cyclohexane derivatives having an analgesic action
11/07/2007EP1851227A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007CN101068795A Heterocyclical chromophore architectures with novel electronic acceptor systems
11/07/2007CN101068788A Quinoline as allosteric enhancers of the gaba-b receptors
11/07/2007CN100347173C Pyrazoloquinolines with immunomodulating activity
11/06/2007US7291733 pyrido[3',2':4,5]thieno[3,2-d]-pyrimidines (or triazines or pyridines); inhibitors of the kinase activity of the I kappa B kinase (IKK) complex; autoimmune diseases, inflammatory diseases and cancer; lupus, rheumatoid arthritis, breast canser
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291612 Immunomodulatory compounds
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007121976A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254915 Cxcr4 modulators
11/01/2007US20070254909 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2648895A1 Camptothecin-analog with a novel, "flipped" lactone-stable, e-ring and methods for making and using same
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007CA2641139A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/2007
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848426A2 Tricyclic cytoprotective compounds
10/31/2007EP1537122B9 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1286998B2 Oxazolidinone derivatives with antibiotic activity
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007DE102006019597A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101065016A Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 298